10:30 AM EST - Neovasc, Inc. : Announced that Boston Scientific Corporation closed the acquisition of certain manufacturing assets and capabilities of the Neovasc, Inc. advanced biological tissue business. With the completion of the acquisition, Boston Scientific will integrate certain manufacturing assets and biologic tissue capabilities into its structural heart business for use in the manufacturing of the Lotus™ Valve System* and future heart valve technologies. Neovasc, Inc.
shares T.NVC are trading up $0.37 at $3.32.
